As menopause moves from silence into public conversation, women are turning to testosterone therapy in growing numbers — seeking restoration of energy, desire, and clarity in the hormonal passage of midlife. Yet the infrastructure of medicine has not kept pace with this awakening: insurance systems treat the therapy as suspect, pharmacies struggle to stock it, and many physicians have never been taught to prescribe it at all. What emerges is a familiar human story — a need that is real, a remedy that exists, and a system that has not yet decided whether to make room for both.
Testosterone prescriptions for women surge amid access barriers and scientific debate
Women seeking testosterone therapy experience treatment delays and insurance denials that may worsen menopausal symptoms and quality of life.